Orlistat is the only conventional drug used for obesity treatment through the inhibition of pancreatic lipase, but the side effects of the drug have ignited the hunt to develop plant-based lipase-inhibiting drugs for obesity [50]. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.